Latest DEF 14A proxy statements

ZimVie Inc. issues supplemental disclosures to its merger proxy amid stockholder lawsuits, reaffirms board's unanimous recommendation for Zamboni Parent acquisition.

PROMIS Neurosciences Inc. will hold a Special Meeting on November 17, 2025, to vote on a share consolidation proposal ranging from one-for-five to one-for-twenty-five.

Merus N.V. announced its agreement to be acquired by Genmab for approximately $8 billion in cash, or $97 per common share, representing a significant premium.

Brinker International, Inc. announced its Annual Meeting of Shareholders for November 20, 2025, to vote on director elections, auditor ratification, and executive compensation.

Trailblazer Merger Corporation I stockholders approved amendments to extend the deadline for completing a business combination until March 30, 2026, allowing for monthly extensions.

Advanced Flower Capital Inc. is seeking shareholder approval for two key proposals to facilitate its conversion from a REIT to a Business Development Company (BDC).

Viavi Solutions Inc. announced its annual stockholder meeting for November 12, 2025, outlining proposals including director elections, auditor ratification, executive compensation, equity plan amendments, and officer exculpation.

Callan JMB Inc. has secured an Equity Line of Credit for up to $25 million with Hexstone Capital LLC, approved by majority stockholders to fund operations and growth.

High Roller Technologies, Inc. has filed a Definitive Proxy Statement with the SEC.

CSLM Acquisition Corp. is seeking shareholder approval to extend its business combination deadline until December 18, 2025, to complete its merger with AI provider Fusemachines Inc.

Mawson Infrastructure Group is urging stockholders to vote for all proposals at its upcoming Annual Meeting, including a reverse stock split to maintain Nasdaq listing compliance and the election of a new director.

TON Strategy Company announced its 2025 Virtual Annual Meeting of Stockholders, detailing director elections, executive compensation votes, and significant capital raise activities including a $558 million PIPE financing.

Nova LifeStyle, Inc. will hold a special stockholder meeting to vote on increasing authorized shares, changing its name to XMax Inc., and granting adjournment authority.

ProMIS Neurosciences Inc. will hold a Special Meeting on November 17, 2025, for shareholders to vote on a share consolidation to meet Nasdaq's minimum bid price requirement.

Brinker International's definitive proxy statement highlights exceptional fiscal 2025 financial results and outlines proposals for its upcoming November 2025 annual meeting.

VIAVI Solutions Inc. reports a return to growth in Fiscal Year 2025, driven by diversification into data center and aerospace & defense markets, alongside strategic acquisitions and capital allocation.

High Roller Technologies seeks stockholder approval to amend its equity incentive plan, increasing available shares from 1.7M to 4.2M.

Independent proxy advisory firms Glass Lewis and ISS recommend shareholders vote for Cushman & Wakefield's proposed redomiciliation to Bermuda, citing expected shareholder value creation and cost savings.

ESSA Pharma Inc. is facing a putative class action lawsuit alleging breach of contract and promissory estoppel related to disclosures made prior to its announced business combination with XenoTherapeutics Inc.

Glucotrack, Inc. calls a Special Meeting to approve the issuance of over 20% of its common stock to Sixth Borough Capital Fund, LP for a $20 million equity financing facility.

Firefly Neuroscience, Inc. will hold its Annual Meeting on October 27, 2025, seeking stockholder approval for director elections, auditor ratification, and significant increases in its equity incentive plan and total authorized shares.

GSR III Acquisition Corp. and Terra Innovatum Global S.R.L. announced additional financings totaling $35.16 million and updated beneficial ownership ahead of their business combination.

Coherent Corp. announces its 2025 Annual Meeting of Shareholders to be held on November 13, 2025, featuring director elections, executive compensation vote, and auditor ratification.

XOMA Royalty Corporation and LAVA Therapeutics N.V. announced the extension of the tender offer for LAVA's outstanding shares until October 17, 2025.

REPOSITRAK, INC. has filed Definitive Additional Materials with the SEC, indicating further proxy solicitations.

Sysco Corporation has filed a Definitive Proxy Statement (Schedule 14A) with the U.S. Securities and Exchange Commission.

Sysco Corporation announced record annual revenue of $81.4 billion for fiscal year 2025, alongside strategic initiatives aimed at accelerating profitable growth in fiscal year 2026.

Tesla is soliciting shareholder proxies for its 2025 Annual Meeting, emphasizing a vision of 'Sustainable Abundance' and future transformational growth.

SelectQuote, Inc. has filed a definitive proxy statement with the SEC, indicating an upcoming shareholder meeting.

ResMed Inc. announces its 2025 Annual Meeting of Stockholders, outlining proposals including director elections, auditor ratification, executive compensation, and incentive plan amendments.